All Stories

  1. Structure–Activity Relationship Study of Protoberberine Alkaloids Reveals Molecular Planarity as a Key Determinant of Membrane Interaction and Protection from Misfolded Protein Oligomers
  2. Complex coacervation reshapes the aggregation landscape of tau
  3. Prediction of antibody non-specificity using protein language models and biophysical parameters
  4. Effects of PTMs on Tau Protein Aggregation: Insights from HCG and Atomistic MD Simulations
  5. Does the sequence of a disordered protein encode small molecule binding paths?
  6. Microglia as transcriptional pacemakers of neuronal aging heterogeneity across individuals
  7. Rapid elongation drives the exceptionally fast aggregation of the most common localized human amyloid medin
  8. Systems-level organization of extracellular proteostasis
  9. OmniBind: Proteome-Wide Promiscuity Predictions for Early-Stage Drug Screening
  10. The α-synuclein proteostasis network and its translational applications in Parkinson’s disease
  11. FuzDrop: sequence-based prediction of the propensity of proteins for liquid–liquid phase separation and aggregation
  12. Metadiffusion: inference-time meta-energy biasing of biomolecular diffusion models
  13. Single-molecule imaging of small aggregates of IAPP in type 2 diabetes serum with rationally-designed antibody-like scaffolds
  14. In vitro and in vivo inhibition of amyloid β aggregation by a Ru( ii )–naphthalene diimide complex
  15. Destabilization of Helix III Initiates Early Serum Amyloid A Misfolding by Exposing Its Amyloidogenic Core
  16. Binding Paths: Describing Small Molecule Interactions with Disordered Proteins via Markov State Models
  17. Identification of potent high-affinity secondary nucleation inhibitors of Aβ42 aggregation from an ultra-large chemical library using deep docking
  18. Serial amplification of tau filaments using Alzheimer's brain homogenates and C322A or C322S recombinant tau
  19. Nanoscale profiling of evolving intermolecular interactions in ageing FUS condensates
  20. Rapid elongation drives the exceptionally fast aggregation of medin, the most common localized human amyloid
  21. Structure-based Generation of a Secondary Nucleation Inhibitor in α-Synuclein Aggregation Using a Conditional Diffusion Model
  22. Classification of Tauopathies from Human Brain Homogenates through Salt-Modulated Tau Amplification
  23. Recruitment of Aβ into α-Synuclein Condensates Catalyzes Primary Nucleation of α-Synuclein Aggregation
  24. Sequence-based virtual screening using transformers
  25. Aβ42 promotes the aggregation of α‐synuclein splice isoforms via heterogeneous nucleation
  26. Amyloid-β modulates the phase separation and aggregation of α-synuclein
  27. Targeted Protein Modification with an Antibody-Based System
  28. Proteostasis signatures in human diseases
  29. The thermodynamic hypothesis of protein aggregation
  30. Destabilization of Helix III Initiates Early Serum Amyloid A Misfolding by Exposing Its Amyloidogenic Core
  31. Prediction of Antibody Non-Specificity using Protein Language Models and Biophysical Parameters
  32. Aggregation of α-synuclein splice isoforms through a phase separation pathway
  33. Linking Aβ and tau in the amyloid cascade through the intersection of their proteostasis networks
  34. Serial amplification of tau filaments using Alzheimer’s brain homogenates and C322A or C322S recombinant tau
  35. Natural aminosterols inhibit NMDA receptors with low nanomolar potency
  36. The α-Synuclein Proteostasis Network and its Translational Applications in Parkinson’s disease
  37. Design of Tau Aggregation Inhibitors Using Iterative Machine Learning and a Polymorph-Specific Brain-Seeded Fibril Amplification Assay
  38. Detection of protein oligomers with nanopores 
  39. AlphaFold prediction of structural ensembles of disordered proteins
  40. Design of Protein Sequences with Precisely Tuned Kinetic Properties
  41. Lipid-induced condensate formation from the Alzheimer’s Aβ peptide triggers amyloid aggregation
  42. Sustainable and Surfactant-Free Synthesis of Negatively Charged Acrylamide Nanogels for Biomedical Applications
  43. Transient interactions between the fuzzy coat and the cross-β core of brain-derived Aβ42 filaments
  44. Structural commonalities determined by physicochemical principles in the complex polymorphism of the amyloid state of proteins
  45. Estimation of Ligand Binding Free Energy Using Multi-eGO
  46. Proteostasis Signatures in Human Diseases
  47. Immuno-moodulin is Differentially Expressed in T Cells and Plasma in Obsessive-Compulsive Disorder Patients
  48. Estimation of ligand binding free energy using multi-eGO.
  49. Language Models for Molecular Dynamics
  50. A scale-invariant log-normal droplet size distribution below the critical concentration for protein phase separation
  51. A scale-invariant log-normal droplet size distribution below the critical concentration for protein phase separation
  52. Organization of the Proteostasis Network of Membraneless Organelles
  53. AlphaFold-Metainference: Prediction of Structural Ensembles of Disordered Proteins
  54. Global kinetic model of lipid-inducedα-synuclein aggregation and its inhibition by small molecules
  55. A rapid in vivo pipeline to identify small molecule inhibitors of amyloid aggregation
  56. TNF⍺-driven Aβ aggregation, synaptic dysfunction and hypermetabolism in human iPSC-derived cortical neurons
  57. AlphaFold2-based prediction of the co-condensation propensity of proteins
  58. Estimation of ligand binding free energy using multi-eGO.
  59. Preparation and Characterization of Zn(II)-Stabilized Aβ42 Oligomers
  60. Step Forward Cross Validation for Bioactivity Prediction: Out of Distribution Validation in Drug Discovery
  61. The αC-β4 loop controls the allosteric cooperativity between nucleotide and substrate in the catalytic subunit of protein kinase A
  62. The αC-β4 loop controls the allosteric cooperativity between nucleotide and substrate in the catalytic subunit of protein kinase A
  63. Identification of high-affinity secondary nucleation inhibitors of Aβ42 aggregation from an ultra-large chemical library using Deep Docking
  64. Pharmacological inhibition of α-synuclein aggregation within liquid condensates
  65. Targeted protein editing with an antibody-based system
  66. Modulation of α-synuclein in vitro aggregation kinetics by its alternative splice isoforms
  67. Maturation-dependent changes in the size, structure and seeding capacity of Aβ42 amyloid fibrils
  68. Sequence-Based Drug Design Using Transformers
  69. Imaging Aβ aggregation by liquid-phase transmission electron microscopy
  70. Transient interactions between the fuzzy coat and the cross-β core of brain-derived Aβ42 filaments
  71. Using Generative Modeling to Endow with Potency Initially Inert Compounds with Good Bioavailability and Low Toxicity
  72. Transient interactions between the fuzzy coat and the cross-β core of brain-derived Aβ42 filaments
  73. Aggregation of the Amyloid-β Peptide (Aβ40) within Condensates Generated through Liquid-Liquid Phase Separation
  74. Nanoscale profiling of evolving intermolecular interactions in ageing FUS condensates
  75. Bayesian Optimization in the Latent Space of a Variational Autoencoder for the Generation of Selective FLT3 Inhibitors
  76. CryoENsemble - a Bayesian approach for reweighting biomolecular structural ensembles using heterogeneous cryo-EM maps
  77. Multiomic prediction of therapeutic targets for human diseases associated with protein phase separation
  78. Pharmacological inhibition of α-synuclein aggregation within liquid condensates
  79. Secondary Processes Dominate the Quiescent, Spontaneous Aggregation of α-Synuclein at Physiological pH with Sodium Salts
  80. Targeted protein modification with an antibody-based system
  81. Determination of the Structure and Dynamics of the Fuzzy Coat of an Amyloid Fibril of IAPP Using Cryo-Electron Microscopy
  82. Amyloid formation as a protein phase transition
  83. Thermodynamic and kinetic approaches for drug discovery to target protein misfolding and aggregation
  84. Formation of amyloid loops in brain tissues is controlled by the flexibility of protofibril chains
  85. Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases
  86. FuzPred: a web server for the sequence-based prediction of the context-dependent binding modes of proteins
  87. Exploration and Exploitation Approaches Based on Generative Machine Learning to Identify Potent Small Molecule Inhibitors of α-Synuclein Secondary Nucleation
  88. AlphaFold Prediction of Structural Ensembles of Disordered Proteins
  89. Extracellular protein homeostasis in neurodegenerative diseases
  90. Spontaneous nucleation and fast aggregate-dependent proliferation of α-synuclein aggregates within liquid condensates at neutral pH
  91. Combinations of Vitamin A and Vitamin E Metabolites Confer Resilience against Amyloid-β Aggregation
  92. Sequence-based prediction of pH-dependent protein solubility using CamSol
  93. AlphaFold Prediction of Structural Ensembles of Disordered Proteins
  94. Enhanced surface nanoanalytics of transient biomolecular processes
  95. Fragment-based computational design of antibodies targeting structured epitopes
  96. Sequence-based Prediction of the Cellular Toxicity Associated with Amyloid Aggregation within Protein Condensates
  97. Protein condensation diseases: therapeutic opportunities
  98. ATP-competitive inhibitors modulate the substrate binding cooperativity of a kinase by altering its conformational entropy
  99. Adsorption free energy predicts amyloid protein nucleation rates
  100. π-Clamp-Mediated Homo- and Heterodimerization of Single-Domain Antibodies via Site-Specific Homobifunctional Conjugation
  101. Are casein micelles extracellular condensates formed by liquid‐liquid phase separation?
  102. A Small Molecule Stabilizes the Disordered Native State of the Alzheimer’s Aβ Peptide
  103. Determination of the structure and dynamics of the fuzzy coat of an amyloid fibril of IAPP using cryo-electron microscopy
  104. FuzDrop on AlphaFold: visualizing the sequence-dependent propensity of liquid–liquid phase separation and aggregation of proteins
  105. Conformational Entropy as a Potential Liability of Computationally Designed Antibodies
  106. Kinetic profiling of therapeutic strategies for inhibiting the formation of amyloid oligomers
  107. A Machine Learning Approach to Identify Small Molecule Inhibitors of Secondary Nucleation in α-Synuclein Aggregation
  108. Sequence Determinants of the Aggregation of Proteins Within Condensates Generated by Liquid-liquid Phase Separation
  109. Squalamine and trodusquemine: two natural products for neurodegenerative diseases, from physical chemistry to the clinic
  110. Common sequence motifs of nascent chains engage the ribosome surface and trigger factor
  111. Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease
  112. Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation
  113. A Structural Ensemble of a Tau-Microtubule Complex Reveals Regulatory Tau Phosphorylation and Acetylation Mechanisms
  114. A small molecule stabilises the disordered native state of the Alzheimer’s Aβ peptide
  115. Vitamin A and vitamin E metabolites comodulate amyloid-β aggregation
  116. The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends
  117. The signal peptide of the amyloid precursor protein forms amyloid-like aggregates and enhances Aβ42 aggregation
  118. A maximum caliber approach for continuum path ensembles
  119. The Amyloid-β Pathway in Alzheimer’s Disease
  120. Quantitative Measurement of the Affinity of Toxic and Nontoxic Misfolded Protein Oligomers for Lipid Bilayers and of its Modulation by Lipid Composition and Trodusquemine
  121. Publisher Correction: Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response
  122. Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response
  123. Generic nature of the condensed states of proteins
  124. A mistranslation-prone transcriptome underlying polyglutamine expansion diseases
  125. Kinetic analysis reveals that independent nucleation events determine the progression of polyglutamine aggregation in C. elegans
  126. A structural ensemble of a tau-microtubule complex reveals regulatory tau phosphorylation and acetylation mechanisms
  127. Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases
  128. The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition
  129. Aβ Oligomers Dysregulate Calcium Homeostasis by Mechanosensitive Activation of AMPA and NMDA Receptors
  130. Infrared nanospectroscopy reveals the molecular interaction fingerprint of an aggregation inhibitor with single Aβ42 oligomers
  131. Facile Installation of Post-translational Modifications on the Tau Protein via Chemical Mutagenesis
  132. A kinetic ensemble of the Alzheimer’s Aβ peptide
  133. Computational maturation of a single-domain antibody against Aβ42 aggregation
  134. Determination of intermediate state structures in the opening pathway of SARS-CoV-2 spike using cryo-electron microscopy
  135. A method of incorporating rate constants as kinetic constraints in molecular dynamics simulations
  136. Environmental Dependence of the Structure of the C-terminal Domain of the SARS-CoV-2 Envelope Protein
  137. Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
  138. Widespread occurrence of the droplet state of proteins in the human proteome
  139. Sequence determinants of the aggregation of proteins within condensates generated by liquid-liquid phase separation
  140. Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers
  141. A Structural Ensemble of a Tau-Microtubule Complex Reveals Regulatory Tau Phosphorylation and Acetylation Mechanisms
  142. An intrinsically disordered motif regulates the interaction between the p47 adaptor and the p97 AAA+ ATPase
  143. Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
  144. Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors
  145. Kinetic analysis reveals the rates and mechanisms of protein aggregation in a multicellular organism
  146. Direct measurement of lipid membrane disruption connects kinetics and toxicity of Aβ42 aggregation
  147. Single molecule secondary structure determination of proteins through infrared absorption nanospectroscopy
  148. Rational design of a conformation-specific antibody for the quantification of Aβ oligomers
  149. Sequence-based prediction of protein binding mode landscapes
  150. Assessing motor-related phenotypes of Caenorhabditis elegans with the wide field-of-view nematode tracking platform
  151. A kinetic ensemble of the Alzheimer’s Aβ peptide
  152. Author Correction: Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide
  153. Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide
  154. Complexity in Lipid Membrane Composition Induces Resilience to Aβ42 Aggregation
  155. Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-β Peptide Aggregation and Reduces the Toxicity of Its Oligomers
  156. Chris Dobson (1949–2019)
  157. Widespread remodeling of proteome solubility in response to different protein homeostasis stresses
  158. The N-terminal Acetylation of α-Synuclein Changes the Affinity for Lipid Membranes but not the Structural Properties of the Bound State
  159. Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide
  160. Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases
  161. Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases – ERRATUM
  162. Proteome-wide observation of the phenomenon of life on the edge of solubility
  163. Determination of a Structural Ensemble Representing the Dynamics of a G-Quadruplex DNA
  164. Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons
  165. Bacterial production and direct functional screening of expanded molecular libraries for discovering inhibitors of protein aggregation
  166. Probing the dynamic stalk region of the ribosome using solution NMR
  167. Differential Interactome and Innate Immune Response Activation of Two Structurally Distinct Misfolded Protein Oligomers
  168. Determination of protein structural ensembles using cryo-electron microscopy
  169. Expression of the amyloid-β peptide in a single pair of C. elegans sensory neurons modulates the associated behavioural response
  170. Probing the Origin of the Toxicity of Oligomeric Aggregates of α-Synuclein with Antibodies
  171. Identifying A- and P-site locations on ribosome-protected mRNA fragments using Integer Programming
  172. The free energy landscape of the oncogene protein E7 of human papillomavirus type 16 reveals a complex interplay between ordered and disordered regions
  173. Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates
  174. A method of predicting the in vitro fibril formation propensity of Aβ40 mutants based on their inclusion body levels in E. coli
  175. Atomic force microscopy for single molecule characterisation of protein aggregation
  176. A superposition free method for protein conformational ensemble analyses and local clustering based on a differential geometry representation of backbone
  177. Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes
  178. Effects of α-tubulin acetylation on microtubule structure and stability
  179. Chemical and mechanistic analysis of photodynamic inhibition of Alzheimer's β-amyloid aggregation
  180. Bayesian Weighing of Electron Cryo-Microscopy Data for Integrative Structural Modeling
  181. A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology
  182. Identifying A- and P-site locations on ribosome-protected mRNA fragments using Integer Programming
  183. In vitro and in silico assessment of the developability of a designed monoclonal antibody library
  184. Determination of Structural Ensembles of Proteins: Restraining vs Reweighting
  185. Automated Behavioral Analysis of Large C. elegans Populations Using a Wide Field-of-view Tracking Platform
  186. SAR by kinetics for drug discovery in protein misfolding diseases
  187. Microfluidic deposition for resolving single-molecule protein architecture and heterogeneity
  188. Intrinsically aggregation-prone proteins form amyloid-like aggregates and contribute to tissue aging in C. elegans
  189. Fast fluorescence lifetime imaging reveals the aggregation processes of α-synuclein and polyglutamine in aging Caenorhabditis elegans
  190. Systematic mapping of free energy landscapes of a growing filamin domain during biosynthesis
  191. Stabilization and Characterization of Cytotoxic Aβ40 Oligomers Isolated from an Aggregation Reaction in the Presence of Zinc Ions
  192. Author Correction: The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation
  193. Structural Ensemble Modulation upon Small-Molecule Binding to Disordered Proteins
  194. Massively parallel C. elegans tracking provides multi-dimensional fingerprints for phenotypic discovery
  195. Molecular dynamics ensemble refinement of the heterogeneous native state of NCBD using chemical shifts and NOEs
  196. Determination of the conformational states of strychnine using NMR residual dipolar couplings in a tensor-free approach
  197. Exploring the role of post-translational modifications in regulating α-synuclein interactions by studying the effects of phosphorylation on nanobody binding
  198. Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine
  199. Reversible inhibition of the ClpP protease via an N-terminal conformational switch
  200. Cooperative Assembly of Hsp70 Subdomain Clusters
  201. A method for partitioning the information contained in a protein sequence between its structure and function
  202. A Rationally Designed Hsp70 Variant Rescues the Aggregation-Associated Toxicity of Human IAPP in Cultured Pancreatic Islet β-Cells
  203. Developing NMR methods for macromolecular machines: Measurement of residual dipolar couplings to probe dynamical regions of the ribosome
  204. Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes
  205. Chemical Kinetics for Bridging Molecular Mechanisms and Macroscopic Measurements of Amyloid Fibril Formation
  206. Parapred: antibody paratope prediction using convolutional and recurrent neural networks
  207. FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions
  208. Simultaneous Determination of Protein Structure and Dynamics Using Cryo-Electron Microscopy
  209. Molecular determinants of the interaction of EGCG with ordered and disordered proteins
  210. Distinct thermodynamic signatures of oligomer generation in the aggregation of the amyloid-β peptide
  211. Molecular dynamics ensemble refinement of the heterogeneous native state of NCBD using chemical shifts and NOEs
  212. Third generation antibody discovery methods:in silicorational design
  213. Structural differences between toxic and nontoxic HypF-N oligomers
  214. Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers
  215. Simultaneous Determination of Protein Structure and Dynamics Using Cryo-Electron Microscopy
  216. MobiDB 3.0: more annotations for intrinsic disorder, conformational diversity and interactions in proteins
  217. Delivery of Native Proteins into C. elegans Using a Transduction Protocol Based on Lipid Vesicles
  218. Oxetane Grafts Installed Site-Selectively on Native Disulfides to Enhance Protein Stability and Activity In Vivo
  219. In Vitro and In Silico Activity of Iridoids Against Leishmania ama-zonensis
  220. Influence of Harvest Season and Cultivar on the Variation of Phenolic Compounds Composition and Antioxidant Properties in Vaccinium ashei Leaves
  221. Systematic mapping of the free energy landscapes of a growing immunoglobulin domain identifies a kinetic intermediate associated with co-translational proline isomerization
  222. Paratope Prediction using Convolutional and Recurrent Neural Networks
  223. Sequence Specificity in the Entropy-Driven Binding of a Small Molecule and a Disordered Peptide
  224. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation
  225. Rapid and accurate in silico solubility screening of a monoclonal antibody library
  226. Monomeric and fibrillar α-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of Aβ42 aggregates
  227. Nanobodies raised against monomeric ɑ-synuclein inhibit fibril formation and destabilize toxic oligomeric species
  228. Protein homeostasis of a metastable subproteome associated with Alzheimer’s disease
  229. Methods of probing the interactions between small molecules and disordered proteins
  230. Amyloid-like Fibrils from an α-Helical Transmembrane Protein
  231. Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication
  232. Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method
  233. Corrigendum: Structural basis of synaptic vesicle assembly promoted by α-synuclein
  234. Structural Characterization of the Early Events in the Nucleation–Condensation Mechanism in a Protein Folding Process
  235. The RNF168 paralog RNF169 defines a new class of ubiquitylated histone reader involved in the response to DNA damage
  236. Emergence and evolution of an interaction between intrinsically disordered proteins
  237. Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS
  238. MOAG-4 promotes the aggregation of α-synuclein by competing with self-protective electrostatic interactions
  239. Simultaneous quantification of protein order and disorder
  240. Bayesian weighing of electron cryo-microscopy data for integrative structural modeling
  241. Identification of an RNA Polymerase III Regulator Linked to Disease-Associated Protein Aggregation
  242. Inhibition of α-Synuclein Fibril Elongation by Hsp70 Is Governed by a Kinetic Binding Competition between α-Synuclein Species
  243. Widespread Proteome Remodeling and Aggregation in Aging C. elegans
  244. Networks of Dynamic Allostery Regulate Enzyme Function
  245. Principles of protein structural ensemble determination
  246. A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity
  247. Scaling behaviour and rate-determining steps in filamentous self-assembly
  248. Simultaneous NMR characterisation of multiple minima in the free energy landscape of an RNA UUCG tetraloop
  249. Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer’s disease
  250. β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces
  251. Simultaneous Production of Amyloglucosidase and Exo-Polygalacturonase by Aspergillus niger in a Rotating Drum Reactor
  252. Structural basis of synaptic vesicle assembly promoted by α-synuclein
  253. Mutations associated with familial Parkinson’s disease alter the initiation and amplification steps of α-synuclein aggregation
  254. Metadynamic metainference: Enhanced sampling of the metainference ensemble using metadynamics
  255. A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimers disease
  256. Towards a structural biology of the hydrophobic effect in protein folding
  257. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein
  258. Structure of a low-population binding intermediate in protein-RNA recognition
  259. Structural Ensembles of Membrane-bound α-Synuclein Reveal the Molecular Determinants of Synaptic Vesicle Affinity
  260. Structural Effects of Two Camelid Nanobodies Directed to Distinct C-Terminal Epitopes on α-Synuclein
  261. Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability
  262. Structural characterization of the interaction of α-synuclein nascent chains with the ribosomal surface and trigger factor
  263. A transcriptional signature of Alzheimer’s disease is associated with a metastable subproteome at risk for aggregation
  264. Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation
  265. Identification and Structural Characterization of an Intermediate in the Folding of the Measles Virus X Domain
  266. A structural ensemble of a ribosome–nascent chain complex during cotranslational protein folding
  267. A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins
  268. Molecular Recognition by Templated Folding of an Intrinsically Disordered Protein
  269. An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic A 42 aggregates linked with Alzheimers disease
  270. Microfluidic Diffusion Analysis of the Sizes and Interactions of Proteins under Native Solution Conditions
  271. Metainference: A Bayesian inference method for heterogeneous systems
  272. Hamiltonian Dynamics of Protein Filament Formation
  273. Molecular mechanisms of protein aggregation from global fitting of kinetic models
  274. Particle-Based Monte-Carlo Simulations of Steady-State Mass Transport at Intermediate Péclet Numbers
  275. Structural Insights into the Calcium-Mediated Allosteric Transition in the C-Terminal Domain of Calmodulin from Nuclear Magnetic Resonance Measurements
  276. Using Pseudocontact Shifts and Residual Dipolar Couplings as Exact NMR Restraints for the Determination of Protein Structural Ensembles
  277. Parmbsc1: a refined force field for DNA simulations
  278. Structure-Free Validation of Residual Dipolar Coupling and Paramagnetic Relaxation Enhancement Measurements of Disordered Proteins
  279. ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function
  280. Mapping the Protein Fold Universe Using the CamTube Force Field in Molecular Dynamics Simulations
  281. The inverted free energy landscape of an intrinsically disordered peptide by simulations and experiments
  282. Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies
  283. Latent analysis of unmodified biomolecules and their complexes in solution with attomole detection sensitivity
  284. Targeting disordered proteins with small molecules using entropy
  285. Chromatin Unfolding by Epigenetic Modifications Explained by Dramatic Impairment of Internucleosome Interactions: A Multiscale Computational Study
  286. A Rational Design Strategy for the Selective Activity Enhancement of a Molecular Chaperone toward a Target Substrate
  287. Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins
  288. Probing the Residual Structure of the Low Populated Denatured State of ADA2h under Folding Conditions by Relaxation Dispersion Nuclear Magnetic Resonance Spectroscopy
  289. Reply to “Comment on ‘A Tensor-Free Method for the Structural and Dynamic Refinement of Proteins using Residual Dipolar Couplings’”
  290. Dynamic binding mode of a Synaptotagmin-1–SNARE complex in solution
  291. Analysis of the performance of the CHESHIRE and YAPP methods at CASD-NMR round 3
  292. Structure and Dynamics of GeoCyp: A Thermophilic Cyclophilin with a Novel Substrate Binding Mechanism That Functions Efficiently at Low Temperatures
  293. Widespread Proteome Remodeling and Aggregation in Aging C. elegans
  294. Structure and Dynamics of the Integrin LFA-1 I-Domain in the Inactive State Underlie its Inside-Out/Outside-In Signaling and Allosteric Mechanisms
  295. The physical basis of protein misfolding disorders
  296. A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
  297. Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation
  298. The s2D Method: Simultaneous Sequence-Based Prediction of the Statistical Populations of Ordered and Disordered Regions in Proteins
  299. Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases
  300. A Tensor-Free Method for the Structural and Dynamical Refinement of Proteins using Residual Dipolar Couplings
  301. Structure of a low-population intermediate state in the release of an enzyme product
  302. The CamSol Method of Rational Design of Protein Mutants with Enhanced Solubility
  303. Analysis of the hierarchical structure of the B. subtilis transcriptional regulatory network
  304. The Computational Studies of Co-Translational Protein Folding
  305. Biophysical approaches for the study of interactions between molecular chaperones and protein aggregates
  306. Druggability of Intrinsically Disordered Proteins
  307. Structure and Dynamics of Intrinsically Disordered Proteins
  308. The H50Q Mutation Induces a 10-fold Decrease in the Solubility of α-Synuclein
  309. Characterization of the Conformational Fluctuations in the Josephin Domain of Ataxin-3
  310. A Relationship between the Transient Structure in the Monomeric State and the Aggregation Propensities of α-Synuclein and β-Synuclein
  311. ADP ribosylation adapts an ER chaperone response to short-term fluctuations in unfolded protein load
  312. Understanding the frustration arising from the competition between function, misfolding, and aggregation in a globular protein
  313. Identification and characterization of PKCγ, a kinase associated with SCA14, as an amyloidogenic protein
  314. NMR characterization of the conformational fluctuations of the human lymphocyte function‐associated antigen‐1 I‐domain
  315. Equilibrium simulations of proteins using molecular fragment replacement and NMR chemical shifts
  316. Archaeal MBF1 binds to 30S and 70S ribosomes via its helix–turn–helix domain
  317. Cyclophilin A catalyzes proline isomerization by an electrostatic handle mechanism
  318. Statistical Mechanics of the Denatured State of a Protein Using Replica-Averaged Metadynamics
  319. A tensor-free method for the structural and dynamical refinement of proteins using residual dipolar couplings
  320. Flexible anchoring of archaeal MBF1 on ribosomes suggests role as recruitment factor
  321. Erratum: The amyloid state and its association with protein misfolding diseases
  322. Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour
  323. The amyloid state and its association with protein misfolding diseases
  324. Understanding the Influence of Codon Translation Rates on Cotranslational Protein Folding
  325. Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation
  326. Determination of the Individual Roles of the Linker Residues in the Interdomain Motions of Calmodulin Using NMR Chemical Shifts
  327. ALMOST: An all atom molecular simulation toolkit for protein structure determination
  328. Spatial Propagation of Protein Polymerization
  329. Chemical kinetics for drug discovery to combat protein aggregation diseases
  330. Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease
  331. The dynamics of interleukin‐8 and its interaction with human CXC receptor I peptide
  332. A Conformational Ensemble Derived Using NMR Methyl Chemical Shifts Reveals a Mechanical Clamping Transition That Gates the Binding of the HU Protein to DNA
  333. New opportunities for tensor-free calculations of residual dipolar couplings for the study of protein dynamics
  334. A Simple Lattice Model That Captures Protein Folding, Aggregation and Amyloid Formation
  335. Kinetic modelling indicates that fast-translating codons can coordinate cotranslational protein folding by avoiding misfolded intermediates
  336. Structure of a Misfolded Intermediate of a PDZ Domain
  337. Higher Order Amyloid Fibril Structure by MAS NMR and DNP Spectroscopy
  338. A Clear View of Polymorphism, Twist, and Chirality in Amyloid Fibril Formation
  339. Replica-Averaged Metadynamics
  340. Widespread Aggregation and Neurodegenerative Diseases Are Associated with Supersaturated Proteins
  341. pE-DB: a database of structural ensembles of intrinsically disordered and of unfolded proteins
  342. Erratum: “Molecular dynamics simulations with replica-averaged structural restraints generate structural ensembles according to the maximum entropy principle” [J. Chem. Phys. 138, 094112 (2013)]
  343. Subdomain Architecture and Stability of a Giant Repeat Protein
  344. Cucurbit[8]uril and Blue-Box: High-Energy Water Release Overwhelms Electrostatic Interactions
  345. A Relationship between the Aggregation Rates of α-Synuclein Variants and the β-Sheet Populations in Their Monomeric Forms
  346. Characterization of the Interdomain Motions in Hen Lysozyme Using Residual Dipolar Couplings as Replica-Averaged Structural Restraints in Molecular Dynamics Simulations
  347. Structures of the Excited States of Phospholamban and Shifts in Their Populations upon Phosphorylation
  348. In-Cell NMR Characterization of the Secondary Structure Populations of a Disordered Conformation of α-Synuclein within E. coli Cells
  349. A geometrical parametrization of C1′-C5′ RNA ribose chemical shifts calculated by density functional theory
  350. Identification of small-molecule binding pockets in the soluble monomeric form of the Aβ42 peptide
  351. Nanobodies Raised against Monomeric α-Synuclein Distinguish between Fibrils at Different Maturation Stages
  352. Single-Molecule Measurements of Transient Biomolecular Complexes through Microfluidic Dilution
  353. A method of determining RNA conformational ensembles using structure-based calculations of residual dipolar couplings
  354. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
  355. Integration and characterization of solid wall electrodes in microfluidic devices fabricated in a single photolithography step
  356. The codon information index: a quantitative measure of the information provided by the codon bias
  357. Characterization of the free-energy landscapes of proteins by NMR-guided metadynamics
  358. Atomic structure and hierarchical assembly of a cross-β amyloid fibril
  359. Protein self-assembly intermediates
  360. Molecular dynamics simulations with replica-averaged structural restraints generate structural ensembles according to the maximum entropy principle
  361. Erratum: Prediction of variable translation rate effects on cotranslational protein folding
  362. Analysis of the Contributions of Ring Current and Electric Field Effects to the Chemical Shifts of RNA Bases
  363. Assessment of the Use of NMR Chemical Shifts as Replica-Averaged Structural Restraints in Molecular Dynamics Simulations to Characterize the Dynamics of Proteins
  364. R state structure of monomeric phospholamban (C36A, C41F, C46A)
  365. Sequence-Based Prediction of Protein Behavior
  366. The Kinetics and Mechanisms of Amyloid Formation
  367. Characterization of Free Energy Landscapes of Proteins using NMR Spectroscopy
  368. In Vivo Translation Rates Can Substantially Delay the Co-Translational Folding of the E. Coli Cytosolic Proteome
  369. Thermodynamics of an Intrinsically Disordered Protein by Atomistic Simulations
  370. In vivo translation rates can substantially delay the cotranslational folding of the Escherichia coli cytosolic proteome
  371. A Rationally Designed Six-Residue Swap Generates Comparability in the Aggregation Behavior of α-Synuclein and β-Synuclein
  372. Twisting Transition between Crystalline and Fibrillar Phases of Aggregated Peptides
  373. In support of the BMRB
  374. ADP ribosylation adapts an ER chaperone response to short-term fluctuations in unfolded protein load
  375. From Macroscopic Measurements to Microscopic Mechanisms of Protein Aggregation
  376. Sequence-Based Prediction of Protein Solubility
  377. Trigger Factor Slows Co-translational Folding through Kinetic Trapping while Sterically Protecting the Nascent Chain from Aberrant Cytosolic Interactions
  378. Determination of structural fluctuations of proteins from structure-based calculations of residual dipolar couplings
  379. Protein Structure Validation Using Side-Chain Chemical Shifts
  380. Structure of an Intermediate State in Protein Folding and Aggregation
  381. Proteome folding and aggregation
  382. Fibrillogenic propensity of the GroEL apical domain: A Janus-faced minichaperone
  383. Determination of Secondary Structure Populations in Disordered States of Proteins Using Nuclear Magnetic Resonance Chemical Shifts
  384. Characterization of the Conformational Equilibrium between the Two Major Substates of RNase A Using NMR Chemical Shifts
  385. Blind Testing of Routine, Fully Automated Determination of Protein Structures from NMR Data
  386. Prediction of variable translation rate effects on cotranslational protein folding
  387. Determination of Conformational Equilibria in Proteins Using Residual Dipolar Couplings
  388. Experimental free energy surfaces reveal the mechanisms of maintenance of protein solubility
  389. Coarse-grained model for protein folding based on structural profiles
  390. Inversion of the Balance between Hydrophobic and Hydrogen Bonding Interactions in Protein Folding and Aggregation
  391. ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism
  392. Metastability of Native Proteins and the Phenomenon of Amyloid Formation
  393. Nucleated Polymerisation in the Presence of Pre-Formed Seed Filaments
  394. Using Side-Chain Aromatic Proton Chemical Shifts for a Quantitative Analysis of Protein Structures
  395. Using Side-Chain Aromatic Proton Chemical Shifts for a Quantitative Analysis of Protein Structures
  396. Excited-State Control of Protein Activity
  397. The A53T Mutation is Key in Defining the Differences in the Aggregation Kinetics of Human and Mouse α-Synuclein
  398. Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations
  399. Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments
  400. Nucleated polymerization with secondary pathways. III. Equilibrium behavior and oligomer populations
  401. Protein Solubility and Protein Homeostasis: A Generic View of Protein Misfolding Disorders
  402. Using Chemical Shifts to Determine Structural Changes in Proteins upon Complex Formation
  403. Structure-based prediction of methyl chemical shifts in proteins
  404. The statistical theory of allostery
  405. 1H, 13C and 15N resonance assignments of human muscle acylphosphatase
  406. Asymmetric folding pathways and transient misfolding in a coarse-grained model of proteins
  407. Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I
  408. Detection of early locomotor abnormalities in a Drosophila model of Alzheimer's disease
  409. Faculty Opinions recommendation of A transient and low-populated protein-folding intermediate at atomic resolution.
  410. On the Effect of the Ribosome and Trigger Factor on Nascent Chain Protein Folding
  411. New Scenarios of Protein Folding Can Occur on the Ribosome
  412. The iFly tracking system for an automated locomotor and behavioural analysis of Drosophila melanogaster
  413. Interactions in the native state of monellin, which play a protective role against aggregation
  414. Protein Dynamics: Moore's Law in Molecular Biology
  415. Amyloid-like Aggregates Sequester Numerous Metastable Proteins with Essential Cellular Functions
  416. Transient Tertiary Structure Formation within the Ribosome Exit Port
  417. Focus on Physical Principles of Protein Behavior in the Cell
  418. Structural characterization of a misfolded intermediate populated during the folding process of a PDZ domain
  419. Translationally optimal codons associate with aggregation-prone sites in proteins
  420. Accurate Determination of Interstrand Distances and Alignment in Amyloid Fibrils by Magic Angle Spinning NMR
  421. Proteome-Level Interplay between Folding and Aggregation Propensities of Proteins
  422. Enzymatic activity in disordered states of proteins
  423. Functional interactions as a survival strategy against abnormal aggregation
  424. Faculty Opinions recommendation of Widespread protein aggregation as an inherent part of aging in C. elegans.
  425. Using NMR Chemical Shifts as Structural Restraints in Molecular Dynamics Simulations of Proteins
  426. Physicochemical Determinants of Chaperone Requirements
  427. Time Averaging of NMR Chemical Shifts in the MLF Peptide in the Solid State
  428. Intrinsic Determinants of Neurotoxic Aggregate Formation by the Amyloid β Peptide
  429. Faculty Opinions recommendation of NMR spectroscopy brings invisible protein states into focus.
  430. Efficient identification of near-native conformations in ab initio protein structure prediction using structural profiles
  431. Derivation of a solubility condition for proteins from an analysis of the competition between folding and aggregation
  432. Determination of the Free Energy Landscape of α-Synuclein Using Spin Label Nuclear Magnetic Resonance Measurements
  433. An Analytical Solution to the Kinetics of Breakable Filament Assembly
  434. Accurate Random Coil Chemical Shifts from an Analysis of Loop Regions in Native States of Proteins
  435. Analysis of Sub-τc and Supra-τc Motions in Protein Gβ1 Using Molecular Dynamics Simulations
  436. Fast and Accurate Predictions of Protein NMR Chemical Shifts from Interatomic Distances
  437. On the Mechanism of Nonspecific Inhibitors of Protein Aggregation: Dissecting the Interactions of α-Synuclein with Congo Red and Lacmoid
  438. A Condensation-Ordering Mechanism in Nanoparticle-Catalyzed Peptide Aggregation
  439. Factors That Affect the Degree of Twist in β-Sheet Structures: A Molecular Dynamics Simulation Study of a Cross-β Filament of the GNNQQNY Peptide
  440. Physicochemical principles that regulate the competition between functional and dysfunctional association of proteins
  441. Physical Principles of Protein Behavior in the Cell
  442. Folding of Small Proteins by Monte Carlo Simulations with Chemical Shift Restraints without the Use of Molecular Fragment Replacement or Structural Homology
  443. Competition between Intramolecular and Intermolecular Interactions in an Amyloid-Forming Protein
  444. Position-Dependent Electrostatic Protection against Protein Aggregation
  445. A Relationship between mRNA Expression Levels and Protein Solubility in E. coli
  446. Mutational Analysis of the Aggregation-Prone and Disaggregation-Prone Regions of Acylphosphatase
  447. Toward an Accurate Determination of Free Energy Landscapes in Solution States of Proteins
  448. The mechanism of folding of Im7 reveals competition between functional and kinetic evolutionary constraints
  449. Factors That Affect the Degree of Twist in β-Sheet Structures: A Molecular Dynamics Simulation Study of a Cross-β Filament of the GNNQQNY Peptide
  450. Competition between Folding, Native-State Dimerisation and Amyloid Aggregation in β-Lactoglobulin
  451. Correlation between mRNA expression levels and protein aggregation propensities in subcellular localisations
  452. Quantitative approaches to defining normal and aberrant protein homeostasis
  453. Networks in Cell Biology
  454. Self-Templated Nucleation in Peptide and Protein Aggregation
  455. Comparison of successive transition states for folding reveals alternative early folding pathways of two homologous proteins
  456. Determination of Protein Structures in the Solid State from NMR Chemical Shifts
  457. Structure Determination of Protein−Protein Complexes Using NMR Chemical Shifts: Case of an Endonuclease Colicin−Immunity Protein Complex
  458. A Generic Mechanism of Emergence of Amyloid Protofilaments from Disordered Oligomeric Aggregates
  459. Inhibition of α-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region
  460. Introduction to the special issue of GENE
  461. A stochastic method for the reconstruction of protein structures from one-dimensional structural profiles
  462. Competition between protein aggregation and protein complex formation
  463. Structure and Dynamics of a Partially Folded Protein Are Decoupled from Its Mechanism of Aggregation
  464. ChemInform Abstract: The Zyggregator Method for Predicting Protein Aggregation Propensities
  465. Protein dynamics under light control
  466. Characterizing the First Steps of Amyloid Formation for the ccβ Peptide
  467. Prediction by Graph Theoretic Measures of Structural Effects in Proteins Arising from Non-Synonymous Single Nucleotide Polymorphisms
  468. Prediction of Aggregation-Prone Regions in Structured Proteins
  469. Mapping of Two Networks of Residues That Exhibit Structural and Dynamical Changes upon Binding in a PDZ Domain Protein
  470. Biological function in a non-native partially folded state of a protein
  471. A Coupled Equilibrium Shift Mechanism in Calmodulin-Mediated Signal Transduction
  472. Molecular determinants of the aggregation behavior of α- and β-synuclein
  473. Determination of the Transition State Ensemble for the Folding of Ubiquitin from a Combination of Φ and Ψ Analyses
  474. Characterisation of transition state structures for protein folding using 'high', 'medium' and 'low'  -values
  475. Towards quantitative predictions in cell biology using chemical properties of proteins
  476. The Zyggregator method for predicting protein aggregation propensities
  477. Stochastic reconstruction of protein structures from effective connectivity profiles
  478. Calculation of the free energy barriers in the oligomerisation of Ab
  479. Role of Intermolecular Forces in Defining Material Properties of Protein Nanofibrils
  480. The Distribution of Residues in a Polypeptide Sequence Is a Determinant of Aggregation Optimized by Evolution
  481. Influence of the fluctuations of the alignment tensor on the analysis of the structure and dynamics of proteins using residual dipolar couplings
  482. Systematic In Vivo Analysis of the Intrinsic Determinants of Amyloid β Pathogenicity
  483. Importance of Metastable States in the Free Energy Landscapes of Polypeptide Chains
  484. More charges against aggregation
  485. Characterisation of Amyloid Fibril Formation by Small Heat-shock Chaperone Proteins Human αA-, αB- and R120G αB-Crystallins
  486. Molecular dynamics simulations from putative transition states of α-spectrin SH3 domain
  487. Characterization of the nucleation barriers for protein aggregation and amyloid formation
  488. Protein structure determination from NMR chemical shifts
  489. Similarities in the thermodynamics and kinetics of aggregation of disease-related Aβ(1-40) peptides
  490. Life on the edge: a link between gene expression levels and aggregation rates of human proteins
  491. Determination of conformationally heterogeneous states of proteins
  492. Prediction of Local Structural Stabilities of Proteins from Their Amino Acid Sequences
  493. The MUMO (minimal under-restraining minimal over-restraining) method for the determination of native state ensembles of proteins
  494. A PDZ domain recapitulates a unifying mechanism for protein folding
  495. The Structurally Constrained Neutral Model of Protein Evolution
  496. Structural Reorganisation and Potential Toxicity of Oligomeric Species Formed during the Assembly of Amyloid Fibrils
  497. BPPred: A Web-based computational tool for predicting biophysical parameters of proteins
  498. Geometry, Energetics, and Dynamics of Hydrogen Bonds in Proteins:  Structural Information Derived from NMR Scalar Couplings
  499. STRUCTURAL BIOLOGY: Dynamic Visions of Enzymatic Reactions
  500. Characterization of the residual structure in the unfolded state of the Δ131Δ fragment of staphylococcal nuclease
  501. Relation between native ensembles and experimental structures of proteins
  502. Structural Comparison of the Two Alternative Transition States for Folding of TI I27
  503. Theoretical Approaches to Protein Aggregation
  504. Structural Interpretation of Hydrogen Exchange Protection Factors in Proteins: Characterization of the Native State Fluctuations of CI2
  505. Determination of an ensemble of structures representing the intermediate state of the bacterial immunity protein Im7
  506. Effective interactions between chaotropic agents and proteins
  507. Transition State Contact Orders Correlate with Protein Folding Rates
  508. Form of Growing Strings
  509. Determination of the folding transition states of barnase by using Φ I -value-restrained simulations validated by double mutant Φ IJ -values
  510. Interpreting Dynamically-Averaged Scalar Couplings in Proteins
  511. Prediction of “Aggregation-prone” and “Aggregation-susceptible” Regions in Proteins Associated with Neurodegenerative Diseases
  512. Comparison of Sequence-Based and Structure-Based Energy Functions for the Reversible Folding of a Peptide
  513. Detection of non-native hydrophobic interactions in the denatured state of lysozyme by molecular dynamics simulations
  514. A glimpse at the organization of the protein universe
  515. Formation of Native and Non-native Interactions in Ensembles of Denatured ACBP Molecules from Paramagnetic Relaxation Enhancement Studies
  516. Looking at structure, stability, and evolution of proteins through the principal eigenvector of contact matrices and hydrophobicity profiles
  517. Towards complete descriptions of the free–energy landscapes of proteins
  518. Simultaneous determination of protein structure and dynamics
  519. Protein folding and the organization of the protein topology universe
  520. Mapping Long-Range Interactions in α-Synuclein using Spin-Label NMR and Ensemble Molecular Dynamics Simulations
  521. Prediction of Site-Specific Amino Acid Distributions and Limits of Divergent Evolutionary Changes in Protein Sequences
  522. Principal eigenvector of contact matrices and hydrophobicity profiles in proteins
  523. Comparison of the Transition States for Folding of Two Ig-like Proteins from Different Superfamilies
  524. Prediction of the Absolute Aggregation Rates of Amyloidogenic Polypeptide Chains
  525. Low-populated folding intermediates of Fyn SH3 characterized by relaxation dispersion NMR
  526. Molecular Dynamics Studies of the Process of Amyloid Aggregation of Peptide Fragments of Transthyretin
  527. Determination of Protein Structures Consistent with NMR Order Parameters
  528. Reconstruction of Protein Structures from a Vectorial Representation
  529. Transition states for protein folding have native topologies despite high structural variability
  530. Determination of an Ensemble of Structures Representing the Denatured State of the Bovine Acyl-Coenzyme A Binding Protein
  531. Inhibition of protein crystallization by evolutionary negative design
  532. Comparison of the transition state ensembles for folding of Im7 and Im9 determined using all-atom molecular dynamics simulations with ϕ value restraints
  533. Rare Fluctuations of Native Proteins Sampled by Equilibrium Hydrogen Exchange
  534. Structures and relative free energies of partially folded states of proteins
  535. Statistical Properties of Neutral Evolution
  536. Calculation of Mutational Free Energy Changes in Transition States for Protein Folding
  537. Analysis of the distributed computing approach applied to the folding of a small β peptide
  538. Protein folding and misfolding: a paradigm of self–assembly and regulation in complex biological systems
  539. Connectivity of Neutral Networks, Overdispersion, and Structural Conservation in Protein Evolution
  540. Protein folding: bringing theory and experiment closer together
  541. Self-consistent determination of the transition state for protein folding: Application to a fibronectin type III domain
  542. Validity of Gō Models: Comparison with a Solvent-Shielded Empirical Energy Decomposition
  543. Determination of the structures of distinct transition state ensembles for a β-sheet peptide with parallel folding pathways
  544. Determination of a Transition State at Atomic Resolution from Protein Engineering Data
  545. Lack of Self-Averaging in Neutral Evolution of Proteins
  546. Small-world view of the amino acids that play a key role in protein folding
  547. Native and non-native interactions along protein folding and unfolding pathways
  548. Statistical properties of contact vectors
  549. Automated assignment of SCOP and CATH protein structure classifications from FSSP scores
  550. Energetics of enzyme stability
  551. Three key residues form a critical contact network in a protein folding transition state
  552. How to guarantee optimal stability for most representative structures in the protein data bank
  553. Comparison of two optimization methods to derive energy parameters for protein folding: Perceptron and Z score
  554. Toward an energy function for the contact map representation of proteins
  555. Toward an energy function for the contact map representation of proteins
  556. Structurally constrained protein evolution: results from a lattice simulation
  557. A statistical mechanical method to optimize energy functions for protein folding
  558. Can a pairwise contact potential stabilize native protein folds against decoys obtained by threading?
  559. Protein folding using contact maps
  560. Comparison of two optimization methods to derive energy parameters for protein folding: Perceptron andZ score
  561. Folding Lennard-Jones proteins by a contact potential
  562. Neutral Evolution of Model Proteins: Diffusion in Sequence Space and Overdispersion
  563. Hydrophobicity and unique folding of selected polymers
  564. Protein Folding in Contact Map Space
  565. Statistical properties of contact maps
  566. An optimal derivation of a potential for protein folding
  567. Pairwise contact potentials are unsuitable for protein folding
  568. Efficient dynamics in the space of contact maps
  569. High-Dimensional Bak-Sneppen Model
  570. Protein stability and foldability–designability complementarity
  571. Recovery of protein structure from contact maps
  572. Stability Threshold as a Selection Principle for Protein Design
  573. Growth with memory
  574. Modified configurational bias Monte Carlo method for simulation of polymer systems
  575. Model of correlated evolution
  576. Hot sandpiles
  577. Optimal Protein Design Procedure
  578. Diffusion in disordered media as a process with memory
  579. Disordered flat phase and phase diagram for restricted solid-on-solid models of fcc (110) surfaces
  580. Quenched disorder, memory, and self-organization
  581. Evolution of the missing row deconstruction on Rh (110)
  582. A mean-field study of the temperature dependence of the layer magnetizations in a semi-infinite ising model
  583. Magnetic-Phase Transitions of Ising Surfaces with Modified Surface-Bulk Coupling: a Monte Carlo Study
  584. Network views of the cell
  585. Introduction
  586. Protein folding using inter-residue contact